Nanjing Xingang Pharmaceutical

Nanjing Xingang Pharmaceutical is a comprehensive pharmaceutical company based in Nanjing, China, specializing in the research, development, and manufacturing of chemical drugs. Established in 1998, the company has developed a strong portfolio of high-end generic and improved drugs, with a focus on cardiovascular, cerebrovascular, and digestive system therapies. Its commercial success is driven by a range of injectable products, including Alprostadil for vascular disorders and Lansoprazole for gastrointestinal conditions. The company operates the Nanjing Xingang Pharmaceutical Research Institute, which spearheads innovation in drug delivery systems and ensures compliance with generic drug consistency standards. With modern GMP-certified manufacturing facilities, Nanjing Xingang serves as a key player in the Chinese domestic pharmaceutical market.